semaglutide novo nordisk patent The for the key ingredient in Ozempic and Wegovy developed by is set to expire in India on March 20, opening the door for a wave of low-cost China's weight-loss drug makers take

"People are really interested because it's the most efficacious pill right now in the market." Hims' existing patients on compounding semaglutide "will have the opportunity to transition to FDA-approved medicines when determined clinically appropriate by their providers," Hims said in a statement

LifeMD will send prescriptions to the patient's preferred pharmacies

The Unbundled Model: Lower advertised medication price, but services billed separately

320 , E392E398 (2021)

Demand for GLP-1s has skyrocketed

The shortage of tirzepatide, the drug used in Mounjaro and Zepbound, is now marked "resolved." Some experts think this will make it much harder to get compounded versions of the drug